BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2017
View Archived Issues
Shire reports key events of second quarter 2017
Read More
Daiichi Sankyo signs investment contract with Osaka University spin-off Cuorips
Read More
Novel LpxC inhibitor demonstrates efficacy in mouse model of bubonic plague
Read More
Kiromic conducts four phase I/II trials of its TAPA-pulsed dendritic cell vaccine
Read More
Extracellular phosphorylation of EphB2 regulates pathological pain
Read More
First-in-human results for prophylactic mRNA-based rabies vaccine
Read More
Induced pluripotent stem cells used to generate neurons for study of tau aggregation
Read More
Cyclacel selects recommended phase II dose for CYC-065
Read More
Zynerba Pharmaceuticals presents topline data from phase II STAR 1 trial of ZYN-002
Read More
Alligator Bioscience and Stanford University expand immuno-oncology collaboration
Read More
Phase III OPTIMA trial of ThermoDox in primary liver cancer recommended to continue
Read More
Positive topline data from first patient cohort of PIONEER-HCM phase II trial of mavacamten
Read More
FDA issues complete response letter for latanoprostene bunod NDA
Read More
FibroGen reports phase II topline data on pamrevlumab in IPF
Read More
FDA awards orphan drug designation to Mytesi for short bowel syndrome
Read More
Gemphire presents topline data from ROYAL-1 phase IIb study of gemcabene
Read More
Zelboraf granted priority review and breakthrough therapy designation for Erdheim-Chester disease
Read More
Piclidenoson completes cardiodynamic safety study
Read More
Rebiotix initiates phase III trial of RBX-2660 to prevent recurrent C. difficile infection
Read More
Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens
Read More
AntriaBio acquires rights to ActiveSite's plasma kallikrein inhibitor program
Read More
FDA grants orphan drug designation to tesevatinib for EGFR-mutated NSCLC
Read More
Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen
Read More